| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.0086 | 1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |